Sharemaestro company-news research for Danaher Corporation (DHR), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
MEX
Mexico
Measured evidence
Company news sentiment
DHR news sentiment
Danaher Corporation
Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.
Weighted tone60Neutral is 50
Constructive news tone
51/100 evidence confidence
100% direct company focus
2 current stories across 1 publishers
Current company news
News confirmed by price
Constructive news tone is drawn from 2 fresh independent stories, including 2 company-specific items across 1 publishers.
Latest source headline Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination finance.yahoo.com · 11 Aug 2026 12:53What supports the read
2 current stories are mapped specifically to DHR.
Cross-story agreement is 87/100, indicating a comparatively coherent tape.
Constructive news tone is being confirmed by positive weekly price action.
What tempers the read
Only 1 publisher currently contribute to the measured read.
60/100
Weighted toneConstructive news tone
51/100
Evidence confidencebuilding confidence
100%/100
Company focus2 direct stories
87/100
Evidence agreement13/100 dispersion
News history
Tone and story flow over 21 days
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50
Evidence confidence
What supports the score
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Sample depth25
1.98 effective storiesSource breadth20
1 independent publishersDirect relevance100
company-specific evidence shareFreshness65
recency-weighted evidenceAgreement87
cross-story consistencySource independence0
lower publisher concentrationPrice context
Sentiment against the 26-week price path
Constructive news tone is being confirmed by positive weekly price action.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
Sentiment-trend disagreement
News subjects
What is shaping the score
Guidance871 stories · 50%
Regulatory and legal601 stories · 50%
Source mix
Where the evidence comes from
finance.yahoo.com722 stories · 100%
Recurring subjects
Subjects appearing most often
Therapeutic Development1Regulation1Institutional Investors1Healthcare1Guidance1Genome Editing1Fourth Quarter1Earnings1Crispr1Biotech1
Earlier readings
How the score has changed
ConstructiveBalanced or withheldCautious
Source headlines
The news behind the score
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
#160Tone
finance.yahoo.comDirect company coverage
Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination
Nature Communications study finds UNCOVERseq™ delivered the strongest combined sensitivity and precision among evaluated CRISPR off-target nomination methods Findings provide a more rigorous framework for prioritizing potential off-target sites for confirmation and safety assessment in CRISPR-based therapeutic development, supporting more confident progress from promising science toward responsible therapeutic impact Study defines sequencing, replication and process-control conditions relevant to emerging regulatory expectations for genome-editing safety studies CORALVILLE, Iowa, August 11, 20
BioinformaticsCrisprGenome EditingRegulationTherapeutic Development
- Published
- 11 Aug 2026 12:53
- Catalyst
- Regulatory and legal
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
#287Tone
finance.yahoo.comDirect company coverage
Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned?
Thermo Fisher Scientific Inc. (NYSE:TMO) and Danaher Corporation (NYSE:DHR) are two of the world's largest life sciences tools companies, making them natural competitors for investors looking to capitalize on a recovery in pharmaceutical and biotechnology research spending. Both companies delivered better-than-expected second-quarter results, but while Thermo Fisher (NYSE:TMO) raised guidance on broad-based demand improvement, Danaher's (NYSE:DHR) recovery remains more uneven. Which stock looks better positioned for the next phase of the life sciences rebound?Top Long-Term Biotechnology Stocks
BiotechEarningsFourth QuarterGuidanceHealthcareInstitutional Investors
- Published
- 10 Aug 2026 00:01
- Catalyst
- Guidance
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Earlier company news
DHR news archive
Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above.
Aug
08
2026
BenzingaArchivedNeutral tone
Witness A Substantial Acquisition As Christopher Bouda Acquires $96K In Danaher Stock Options
- Published
- 8 Aug 2026 01:18
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Aug
05
2026
Market sourceArchivedNeutral tone
Can Danaher (DHR) Trade At A Discount After Its CEO Change?
- Published
- 5 Aug 2026 13:18
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Aug
03
2026
DirectorsTalk InterviewsArchivedNeutral tone
Danaher Corporation (DHR) Stock Analysis: An 18.86% Upside Potential in the Diagnostics & Research Sector
- Published
- 3 Aug 2026 08:08
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
29
2026
The Globe and MailArchivedNeutral tone
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Danaher (DHR)
- Published
- 29 Jul 2026 12:14
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
27
2026
TechStock²ArchivedNeutral tone
Danaher (NYSE:DHR) Shares Rebound 50% From Post-Earnings Drop, Yet $100 Million Delay Puts Recovery to Test
- Published
- 27 Jul 2026 08:08
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
24
2026
SmartkarmaArchivedNeutral tone
Danaher Corporation’s Stock Price Soars to $192.50, Marking a Robust 7.46% Increase
- Published
- 24 Jul 2026 10:10
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
23
2026
BenzingaArchivedNeutral tone
Danaher Corporation (DHR) technical analysis - Danaher (NYSE:DHR)
- Published
- 23 Jul 2026 10:28
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
21
2026
GuruFocusArchivedPositive tone
Danaher (DHR) Reports Strong Q2 Earnings, Raises Full-Year Guida
- Published
- 21 Jul 2026 13:38
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
20
2026
TrefisArchivedNeutral tone
How Will Danaher Stock React To Its Upcoming Earnings?
- Published
- 20 Jul 2026 17:38
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
17
2026
simplywall.stArchivedNeutral tone
Danaher (DHR) Stock Looks Reasonable Despite Rich Earnings Pricing
- Published
- 17 Jul 2026 13:38
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
16
2026
Market sourceArchivedNeutral tone
Countdown to Danaher (DHR) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
- Published
- 16 Jul 2026 17:28
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
15
2026
Stock TitanArchivedNeutral tone
Lab-products maker StatLab set to join Danaher’s Leica
- Published
- 15 Jul 2026 10:13
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
14
2026
Stock TitanArchivedNeutral tone
[144] DANAHER CORP /DE/ SEC Filing
- Published
- 14 Jul 2026 22:22
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
14
2026
Investing.com NigeriaArchivedNeutral tone
Danaher stock may move 4.9% on July 21 earnings report By Investing.com
- Published
- 14 Jul 2026 15:38
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
13
2026
Seeking AlphaArchivedNeutral tone
Danaher Is Getting Better, But The Stock Still Isn't Cheap (NYSE:DHR)
- Published
- 13 Jul 2026 13:48
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
10
2026
Market sourceArchivedPositive tone
Jim Cramer on Danaher: “I Don’t Want You Anywhere Near That One”
- Published
- 10 Jul 2026 14:48
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
10
2026
Market sourceArchivedPositive tone
Danaher (DHR) Wins CE Mark For Access P Tau217 Assay, Is The Stock A Bargain?
- Published
- 10 Jul 2026 07:22
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
09
2026
simplywall.stArchivedPositive tone
What Danaher (DHR)'s New p-Tau217 Alzheimer’s Assays Mean For Shareholders
- Published
- 9 Jul 2026 20:53
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
08
2026
Quiver QuantitativeArchivedNeutral tone
Danaher slips as investors weigh soft diagnostics trends and Masimo integration risk
- Published
- 8 Jul 2026 06:25
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
06
2026
TradingViewArchivedNeutral tone
Enterprise value to revenue forward of Danaher Corporation – NYSE:DHR
- Published
- 6 Jul 2026 11:34
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
03
2026
simplywall.stArchivedNeutral tone
Danaher (DHR) Stock Weighs DCF Upside Against Premium P/E After Recent Bounce
- Published
- 3 Jul 2026 22:27
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
03
2026
MSNArchivedNeutral tone
What to expect from Danaher's next quarterly earnings report
- Published
- 3 Jul 2026 19:38
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
30
2026
Stock TitanArchivedNeutral tone
$1M Danaher grant targets Ebola outbreak in Congo, Uganda
- Published
- 30 Jun 2026 15:42
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
30
2026
Seeking AlphaArchivedNeutral tone
Danaher: Why I'm Not Paying 24x P/E For 8% EPS Growth (NYSE:DHR)
- Published
- 30 Jun 2026 15:08
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
25
2026
GuruFocusArchivedNeutral tone
A Look at Danaher Corp (DHR) After 5.5% Gain -- GF Value $236.97 vs Price $188.87
- Published
- 25 Jun 2026 04:36
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
24
2026
Stock TitanArchivedNeutral tone
Danaher plans July 21 earnings call, slide deck at 6 a.m. ET
- Published
- 24 Jun 2026 02:08
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
22
2026
AD HOC NEWSArchivedNeutral tone
Danaher Stock - long-term strategy in life sciences
- Published
- 22 Jun 2026 11:02
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
20
2026
simplywall.stArchivedPositive tone
Danaher (DHR) Expands Ebola Testing And AI Drug Filing Push Through Two Subsidiaries
- Published
- 20 Jun 2026 07:55
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
19
2026
Market sourceArchivedPositive tone
Danaher Corporation’s (DHR) Recovery Fell Short of Investor Expectations
- Published
- 19 Jun 2026 05:48
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.